RETRACTED ARTICLE: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug

ABSTRACT: Specific inhibition of the viral RNA-dependent RNA polymerase (RdRp) of the newly-emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a very promising strategy for developing highly potent medicines for coronavirus disease 2019 (COVID-19). However, almost all of the rep...

Descripción completa

Detalles Bibliográficos
Autor principal: Rabie, Amgad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126404/
https://www.ncbi.nlm.nih.gov/pubmed/34025012
http://dx.doi.org/10.1007/s11696-021-01640-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126404/
https://www.ncbi.nlm.nih.gov/pubmed/34025012
http://dx.doi.org/10.1007/s11696-021-01640-9

Ejemplares similares